Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Targeted molecular mechanisms of epoetin alfa
Corey J. Langer
, Fred R. Hirsch
, Hernan Cortés-Funes
, Stephen T. Sawyer
, Nick Thatcher
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted molecular mechanisms of epoetin alfa'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Molecular Mechanism
100%
Epoetin Alfa
100%
Anemia
80%
Quality of Life
60%
Lung Cancer Patients
60%
Treatment Outcome
40%
Survival Time
40%
Lung Cancer
20%
Cognitive Function
20%
Beneficial Effects
20%
Cancer Treatment
20%
Radiotherapy
20%
Cancer Outcomes
20%
Clinical Practice
20%
Poor Prognosis
20%
Current Treatment
20%
Tumor Hypoxia
20%
Potential Gains
20%
Quality of Life Improvement
20%
Molecular Targeted Therapy
20%
Causal Factors
20%
Palliation
20%
Chemotherapy Efficacy
20%
RhEPO
20%
Future Research Needs
20%
Cancer-related Anemia
20%
Mild Anaemia
20%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
100%
Recombinant Erythropoietin
100%
Lung Cancer
66%
Malignant Neoplasm
33%
Survival Time
33%
Hypoxia
16%
Neoplasm
16%
Clinical Study
16%
Chemotherapy Regimens
16%